— Know what they know.
Not Investment Advice
Also trades as: WGSWW (NASDAQ) · $vol 0M

WGS NASDAQ

GeneDx Holdings Corp.
1W: +21.8% 1M: -32.2% 3M: -42.3% YTD: -64.2% 1Y: -34.4% 3Y: +650.1% 5Y: -87.1%
$47.31
-0.02 (-0.04%)
 
Weekly Expected Move ±27.4%
$18 $30 $41 $52 $63
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Sell · Power 38 · $1.4B mcap · 26M float · 4.48% daily turnover · Short 56% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$428M +40.0% ▲
5Y CAGR: +19.0%
Gross Profit
$298M +53.4% ▲
5Y CAGR: +136.5%
Operating Income
-$12M +49.2% ▲
Net Income
-$21M +59.8% ▲
EPS (Diluted)
$-0.73 +62.4% ▲
EBITDA
$7M +625.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$212M$235M$203M$305M$428M
YoY Growth+18.3%+10.6%-13.7%+50.8%+40.0%
Cost of Revenue$229M$261M$113M$111M$129M
Gross Profit-$17M-$27M$90M$194M$298M
Gross Margin-7.8%-11.4%44.4%63.6%69.7%
R&D Expenses$105M$86M$58M$46M$72M
SG&A Expenses$319M$338M$195M$168M$239M
Operating Expenses$430M$641M$271M$218M$311M
Operating Income-$446M-$668M-$181M-$23M-$12M
Operating Margin-210.3%-284.5%-89.2%-7.6%-2.8%
Interest Expense$3M$3M$0$3M$3M
Income Before Tax-$245M-$598M-$177M-$53M-$21M
Tax Expense$0-$49M-$926K-$343K-$116K
Net Income-$245M-$549M-$176M-$52M-$21M
Net Margin-115.6%-233.9%-86.8%-17.1%-4.9%
EPS (Diluted)$-74.93$-53.63$-7.23$-1.94$-0.73
EBITDA-$221M-$398M-$136M-$1M$7M
Shares Outstanding3M10M24M27M27M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms